Therefore, therapeutic strategies targeting IL-18 offer a promising approach for intervening in the pathological progression of AKI, providing a novel therapeutic target for its prevention and treatment (Fig. 2A and Fig. S1). The gene discussed is IL18; the disease is acute kidney injury.